The use of nuclear magnetic resonance imaging in monitoring total body iron in hemodialysis patients with hemosiderosis treated with erythropoietin and phlebotomy.

Abstract	Two hemodialysis patients with hemosiderosis were treated with combined erythropoietin and repeated phlebotomy. Serial nuclear magnetic resonance (NMR) imaging and serum ferritin levels were used to monitor the efficacy of treatment. This treatment modality has definite advantages over chronic deferoxamine therapy. NMR image-derived parameters offer an objective, accurate, and noninvasive indication of tissue iron stores.
Authors	P C Chan, P Liu, C Cronin, J Heathcote, R Uldall
Journal	American journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 19 Issue 5 Pg. 484-9 (May 1992) ISSN: 0272-6386 [Print] United States
PMID	1585939 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Erythropoietin Ferritins Iron
Topics	Adult Aged Bloodletting Erythropoietin (therapeutic use) Female Ferritins (blood) Hemosiderosis (blood, diagnosis, etiology, therapy) Humans Iron (analysis) Liver (chemistry, pathology) Magnetic Resonance Imaging Male Myocardium (chemistry, pathology) Renal Dialysis (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!